Evidence map›Paper›PMID 40530425›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

Treatment outcomes of successful M1 versus M2 thrombectomy for low-ASPECTS stroke patients.

Huanwen Chen, Marco Colasurdo, Hidetoshi Matsukawa, Conor Cunningham, Ilko Maier, Pascal Jabbour, Joon-Tae Kim, Stacey Quintero Wolfe, Ansaar Rai, Robert M Starke and 30 more

Abstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Huanwen ChenDepartment of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.ORCID 0000-0003-2455-748X
Marco ColasurdoDepartment of Interventional Neurology, Oregon Health & Science University Hospital, Portland, OR, USA.ORCID 0000-0002-7823-3088
Hidetoshi MatsukawaDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.
Conor CunninghamDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.
Ilko MaierUniversitätsmedizin Göttingen, Göttingen, Germany.
Pascal JabbourThomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0002-8965-2413
Joon-Tae KimChonnam National University Hospital, Gwangju, Republic of Korea.
Stacey Quintero WolfeWake Forest Baptist Health, Lexington, NC, USA.ORCID 0000-0001-7603-2728
Ansaar RaiWest Virginia University, Morgantown, WV, USA.
Robert M StarkeUniversity of Miami Health System, Miami, FL, USA.
Marios-Nikos PsychogiosUniversitätsspital Basel, Basel, Switzerland.
Amir ShabanUniversity of Iowa, Iowa City, IA, USA.
Nitin GoyalUniversity of Tennessee Health Science Center, Semmes Murphey Foundation, Memphis, TN, USA.
Shinichi YoshimuraHyogo College of Medicine, Hyogo, Japan.ORCID 0000-0001-5633-9132
Hugo CuellarLSU Health Shreveport, Shreveport, LA, USA.ORCID 0000-0002-8348-4535
Brian HowardEmory University, Atlanta, GA, USA.
Ali AlawiehEmory University, Atlanta, GA, USA.
Ali AlarajUniversity of Chicago at Illinois, Chicago, IL, USA.ORCID 0000-0002-1491-4634
Mohamad EzzeldinUniversity of Houston, HCA Houston Healthcare Kingwood, Kingwood, TX, USA.ORCID 0000-0001-7740-8774
Daniele G RomanoAou S. Giovanni di Dio e Ruggi d'Aragona, Salerno, SA, Italy.
Omar TanweerBaylor College of Medicine, Houston, TX, USA.
Justin MascitelliUniversity of Texas Health Science Center at San Antonio, San Antonia, TX, USA.
Isabel FragataNOVA Medical School, Universidade Nova de Lisboa, Lisboa, Portugal.ORCID 0000-0002-7037-7458
Adam PolifkaUniversity of Florida, Gainesville, FL, USA.
Fazeel SiddiquiUniversity of Michigan Health West, Wyoming, MI, USA.
Joshua OsbunWashington University in St Louis, St Louis, MO, USA.
Roberto CrosaMédica Uruguaya, Montevideo, Uruguay.
Ramesh GrandhiUniversity of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-9000-6083
Charles MatoukYale University, New Haven, CT, USA.ORCID 0000-0003-3234-9541
Min S ParkUniversity of Virginia, Charlottesville, VA, USA.
Michael R LevittUniversity of Washington, Seattle, WA, USA.
Waleed BrinjikjiMayo Clinic in Minnesota, Rochester, MN, USA.
Mark MossWashington Regional Medical Center, Fayetteville, AR, USA.
Ergun DagliogluHealth Science University, Ankara Bilkent City Hospital, Ankara, Turkey.
Richard WilliamsonAlleghany Hospital, Pittsburgh, PA, USA.
Pedro NaviaHospital Universitario La Paz, Madrid, Spain.
Shakeel ChowdhryNorth Shore University Health System, Evanston, IL, USA.
David J AltschulMontefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0002-5130-1378
Alejandro M SpiottaDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.
Peter KanDepartment of Neurosurgery, University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Funding

Miami Clinical and Translational Science InstituteUL1TR002736 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN, KOBETZ, ERIN N · 2018 to 2022
$23.2M
Miami Clinical and Translational Science InstituteUM1TR004556 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Olveen Carrasquillo, ERIN N KOBETZ · 2023 to 2026
$16.0M
Institutional Career Development CoreKL2TR002737 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RUNDEK, TATJANA, SCOTT, GWENDOLYN BARBARA · 2018 to 2022
$3.6M
Endothelial cell dysfunction in cerebral aneurysm pathogenesisR01NS111119 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI STARKE, ROBERT MICHAEL · 2020 to 2024
$2.4M
Development of a Wireless Endovascular Nerve Stimulator for Treatment of Refractory Neuropathic PainU18EB029353 · NIBIB · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KAN, PETER TZE MAN, ROBINSON, JACOB T. · 2019 to 2019
$2.3M
Electroencephalographic signatures of dysfunctional cerebrovascular autoregulation as biomarkers of brain injury in aneurysmal subarachnoid hemorrhage (SAH)R21NS128641 · NINDS · YALE UNIVERSITY · PI KIM, JENNIFER A, MATOUK, CHARLES · 2023 to 2024
$461k
NCATS NIH HHS KL2 TR002737NCATS NIH HHS UL1 TR002736NCATS NIH HHS UM1 TR004556NIBIB NIH HHS U18 EB029353NINDS NIH HHS R01 NS111119NINDS NIH HHS R21 NS128641
6 · The paper itself

Abstract

BackgroundThe effectiveness of endovascular thrombectomy (EVT) for low Alberta Stroke Program Early CT score (ASPECTS) stroke patients with occlusion of the second segment of the middle cerebral artery (M2) is unclear.MethodsThis was a multicenter retrospective study. Patients with M1 or M2 occlusions and low ASPECTS (<6) who underwent successful EVT (modified treatment in cerebral ischemia score of 2b or higher) were included. Primary outcome was futile EVT reperfusion (defined as 90-day modified Rankin scale of 5 or 6). Other outcomes of interest include acceptable outcomes (modified Rankin scale of 3 or less) and intracranial hemorrhage (ICH), and all-cause 90-day mortality. Outcomes for M1 patients were compared to M2 patients with multivariable logistic regression models accounting for potential confounders.Results173 patients with M1 or M2 occlusions and low ASPECTS (<6) who underwent successful EVT were identified. After multivariable adjustments, M2 patients had significantly higher odds of futile reperfusion (OR 5.48 [95%CI 1.91 to 15.7], p = 0.002), lower odds of acceptable outcomes (OR 0.33 [95%CI 0.12 to 0.89], p = 0.028), and higher odds of all-cause mortality (OR 4.90 [95%CI 1.65 to 14.5], p = 0.004). These findings suggest that EVT's efficacy for low-ASPECTS stroke patients may be diminished for patients with M2 occlusions. M2 occlusion was not significantly associated with ICH.ConclusionsAmong low-ASEPCTS stroke patients who underwent successful EVT, those with M2 occlusions had significantly higher odds of poor outcome compared to those with M1 occlusions.

Indexed as

ASPECTSM2mediumStrokethrombectomy

Identifiers

PMID40530425
PMCPMC12176791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.